Cancer

Since 1990, proportion of white participants in prostate cancer clinical trials has remained >80 percent Prostate cancer clinical trial participants are overwhelmingly white, according to a study published online June 5 in Cancer Epidemiology, Biomarkers & Prevention. Emily M. Rencsok, from the Harvard T.H. Chan School of Public Health in Boston, and colleagues analyzed 72 global...

By Robin Baumeister When celebrities share their lives on social media, we might expect to see their hobbies, meals, or vacations—definitely not their colonoscopies. But that is exactly what Black-ish star Anthony Anderson did, and for good reason: he wants to make sure that men of color don’t miss this routine exam.  So why are...

Article by. Gerardo Sison Genetic testing is at the forefront of precision medicine and state-of-the-art treatments for cancer. Precision medicine is a valuable part of oncology as it allows cancer patients to receive targeted treatment, avoid adverse events, and experience optimal outcomes. Through precision medicine, physicians can apply more comprehensive treatment methods that revolve around...

MD Newsline recently interviewed urologist and Cofounder of MedAux Dr. Behzad Jazayeri about PSA testing and prostate cancer health disparities in Black men. MD Newsline: Dr. Jazayeri, several studies have found that prostate cancer is more common amongst black men. What makes them much more susceptible? Dr. Jazayeri: This is a question that we have...

Gleason grade, prostate-specific antigen velocity, and imaging markers predict cancer spread FRIDAY, Nov. 20, 2020  — Active surveillance for low-risk prostate cancer is associated with a low risk for cancer spread, according to a study published in the Dec. 1 issue of The Journal of Urology. Peter E. Lonergan, M.D., from the University of California...

Brain tumors are the highest cause of cancer-related death in children, and are one of the deadliest cancer types in adults. However, not all who face this devastating disease will have an equal outcome. Sex, race, and socioeconomic status (SES) are all found to impact both incidence and outcomes of numerous forms of brain cancer....

As researchers continue digging deeper into prostate cancer differences in black men, physicians are left with finding new ways to address disparities in their own communities. Active surveillance remains an option for identifying prostate cancer in black men, although low-grade prostate cancer is more aggressive in this population. Healthcare providers must also take into account...

By Gerardo Sison There is a long-standing history of black men and prostate cancer disparities, as evidenced by numerous studies. Some of the factors impacting racial differences in prostate cancer include screening, diagnosis, and treatment.  One multiple-cohort study from JAMA Oncology assessed prostate cancer outcomes and found that black men with prostate cancer faced multiple...

By: Gerardo Sison In the US, it’s not a question of whether African American men face poorer outcomes from prostate cancer. For every 100,000 white men, there are 105.7 new cases of prostate cancer and for every 100,000 black men, there are 178.3 new cases of prostate cancer.  While thousands of men are diagnosed with...